Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.
Eur J Cancer Care (Engl)
; 26(2)2017 Mar.
Article
in En
| MEDLINE
| ID: mdl-26603828
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Organoplatinum Compounds
/
Peripheral Nervous System Diseases
/
Duloxetine Hydrochloride
/
Gastrointestinal Neoplasms
/
Analgesics
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur J Cancer Care (Engl)
Journal subject:
ENFERMAGEM
/
NEOPLASIAS
Year:
2017
Document type:
Article